← 返回前沿论文

使用基于阻抗的生长方法分析 NK-92 在鼻咽癌细胞系和患者来源异种移植模型中的细胞毒性

英文原题:Analysis of NK-92 cytotoxicity in nasopharyngeal carcinoma cell lines and patient-derived xenografts using impedance-based growth method.

PubMed 2023/06/25(内容时间) Heliyon

研究概要

自然杀伤(NK)细胞是先天免疫细胞,无需抗原致敏即可清除病毒感染细胞和肿瘤细胞。

中文摘要

自然杀伤(NK)细胞是先天免疫细胞,无需抗原致敏即可清除病毒感染细胞和肿瘤细胞。这一特性使NK细胞相较于其他免疫细胞在鼻咽癌(NPC)治疗中具有潜在优势。在本研究中,我们报道了如何利用xCELLigence RTCA系统(一种实时、无标记、基于阻抗的监测平台),以效应NK-92细胞(一种市售NK细胞系)对靶NPC细胞系和患者来源异种移植(PDX)细胞进行细胞毒性评估。通过RTCA检测细胞活力、增殖和细胞毒性。同时通过显微镜监测细胞形态、生长和细胞毒性。RTCA和显微镜显示,靶细胞和效应细胞在共培养培养基中均能正常增殖并保持原有形态,与其各自培养基中相同。随着靶细胞与效应细胞(T:E)比例增加,RTCA测得的以任意细胞指数(CI)值表示的细胞活力在所有细胞系和PDX细胞中均下降。NPC PDX细胞对NK-92细胞的细胞毒性作用比NPC细胞系更敏感。这些数据通过基于GFP的显微镜得到证实。我们展示了RTCA系统如何用于癌症研究中NK细胞效应的高通量筛选,以获取细胞活力、增殖和细胞毒性等数据。

展开英文摘要原文

Natural killer (NK) cells are innate immune cells that can remove viral-infected tumour cells without antigen priming. This characteristic offers NK cells an edge over other immune cells as a potential therapy for nasopharyngeal carcinoma (NPC). In this study, we report how cytotoxicity was evaluated in target NPC cell lines and patient-derived xenograft (PDX) cells with effector NK-92, a commercially available NK cell line, by using xCELLigence RTCA system (a real-time, label-free impedance-based monitoring platform). Cell viability, proliferation and cytotoxicity were examined by RTCA. Cell morphology, growth and cytotoxicity were also monitored by microscopy. RTCA and microscopy showed that both target and effector cells were able to proliferate normally and to maintain original morphology in co-culture medium as they were in their own respective culture medium. As target and effector (T:E) cell ratios increased, cell viability as measured by arbitrary cell index (CI) values in RTCA decreased in all cell lines and PDX cells. NPC PDX cells were more sensitive to the cytotoxicity effect of NK-92 cells, than the NPC cell lines. These data were substantiated by GFP-based microscopy. We have shown how the RTCA system can be used for a high throughput screening of the effects of NK cells in cancer studies to obtain data such as cell viability, proliferation and cytotoxicity.

论文信息

作者
Abd Talib FNA、Marzuki M、Hoe SLL
单位
Molecular Pathology Unit, Cancer Research Centre, Institute for Medical Research, National Institutes of Health, Ministry of Health Malaysia, No. 1 Jalan Setia Murni U13/15, Seksyen U13, 40170, Shah Alam, Selangor, Malaysia.Malaysia
期刊
Heliyon2023 Jul
原文标识
PubMed 37415945 · DOI 10.1016/j.heliyon.2023.e17480